Clinical study
BT100
Bacteriophage Therapy of Difficult-to-treat Infections
| Status | Completed |
|---|---|
| Type | Observational study |
| Countries | Location not listed |
| Conditions studied | Bacterial Infections |
| Study years | 2008–2021 |
| Entry review | 2026-10-03 |
Participation
Check the study record or contact the study team for current recruitment and eligibility.
Study eligibility
Inclusion Criteria: * Patients with difficult-to-treat bacterial infections Exclusion Criteria: * None
Study description
A retrospective, observational analysis of the first one hundred consecutive cases of bacteriophage therapy of difficult-to-treat infections, facilitated by a Belgian consortium.
Study registrations
| ClinicalTrials.gov | NCT05498363 |
|---|
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Study ID | nct05498363 |
|---|